AB Science is a Pharmaceutical Company specializing in the research, development, and commercialization of novel targeted therapies named tyrosine kinase inhibitors. Our target diseases are cancers, inflammatory diseases, and central nervous system diseases, in both human and veterinary medicine. The most advanced compound in the development process is masitinib. In veterinary medicine, masitinib (animal medicine trade name Masivet® in Europe or Kinavet® in USA) was registered as a canine cancer therapy by the European Union in November 2008, following a centralized review procedure from the European MedicineAgency. In human medicine, masitinib completed phase 2 clinical studies in eight indications with positive results and three international phase 3 clinical studies have been initiated with this drug, including pancreatic cancer, gastrointestinal stromal tumor and mastocytosis (an orphan disease). AB Science has developed a substantial portfolio of compounds and has several lead candidates in preclinical development.

AB Vista is an international supplier of new generation micro-ingredients for the animal feed industry. Products include enhanced animal performance, greater consumer acceptability or improved production efficiencies.

Power, control and information solutions and services that help solve manufacturing problems. Product brands include Allen-Bradley and Rockwell Software.

Allen-Bradley products from Rockwell Automation include integrated control and information platforms, intelligent motor control and industrial components.